Olivia M. Stransky

Olivia M. Stransky

Auto-generated profile, based on publicly available information

Olivia M. Stransky

Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
TKTraci M. Kazmerski
Traci M. Kazmerski
OSOlivia M. Stransky
Olivia M. Stransky
DLDanielle Rose Lavage
Danielle Rose Lavage
JTJennifer L. Taylor-Cousar
Jennifer L. Taylor-Cousar
GSGregory S. Sawicki
Gregory S. Sawicki
RJRaksha Jain
Raksha Jain

12 February 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
ACAlison R. Clarke
Alison R. Clarke
OSOlivia M. Stransky
Olivia M. Stransky
MBMiriam Bernard
Miriam Bernard
KHKara S. Hughan
Kara S. Hughan
SLSigrid Ladores
Sigrid Ladores
TKTraci M. Kazmerski
Traci M. Kazmerski

1 January 2022 in Journal of Patient Experience
Verified
Journal Article
Open access
OSOlivia M. Stransky
Olivia M. Stransky
MPMolly Pam
Molly Pam
SLSigrid L. Ladores
Sigrid L. Ladores
MTMehret Birru Talabi
Mehret Birru Talabi
SBSonya Borrero
Sonya Borrero
TKTraci M. Kazmerski
Traci M. Kazmerski
Objective: More people with cystic fibrosis (pwCF) are reaching adulthood and considering their reproductive futures. Unfortunately, many pwCF report gaps in their reproductive healthcare. We describe measures of stakeholder engagement in developing a reproductive goals decision aid for women with CF called MyVoice:CF. Methods: Stakeholders reviewed the content, design, and usability of the tool, which was informed by prior research related to CF family planning experiences and preferences as well as a conceptual understanding of reproductive decision making. We evaluated stakeholder engagement via process measures and outcomes of stakeholder involvement. We collected data via recorded stakeholder recommendations and surveys. Results: Fourteen stakeholders participated and the majority described their role on the project as “collaborator”, “advisor”, or “expert.” Most felt their expectations for the project were met or exceeded, that they had contributed significantly, and that they received sufficient and frequent information about the process. All stakeholders provided recommen­dations and clarified aims for a CF-specific family planning tool, including its content and focus on facilitating shared decision making. Discussion: Utilizing meaningful stakeholder contributions, we developed MyVoice:CF, a novel web-based decision aid to help women with CF engage in shared decision-making regarding their reproductive goals. Practical Value: Our findings from working with stakeholders for MyVoice:CF indicate that disease-specific reproductive health resources can and should be designed with input from individuals in the relevant communities.

27 February 2023 in Pediatric Pulmonology
Verified
Journal Article
Closed access
OSOlivia M. Stransky
Olivia M. Stransky
SBSavvy Benipal
Savvy Benipal
MPMolly Pam
Molly Pam
Jennifer L TaylorJennifer L Taylor
Jennifer L Taylor
PDPatricia Documet
Patricia Documet
TKTraci M. Kazmerski
Traci M. Kazmerski

13 March 2024 in Journal of Cystic Fibrosis
Verified
Journal Article
Open access
TKTraci M Kazmerski
Traci M Kazmerski
CMChristie Moy
Christie Moy
EAEnid Aliaj
Enid Aliaj
JHJessica Hudson
Jessica Hudson
BWBrandon Wright
Brandon Wright
RJRaksha Jain
Raksha Jain
Background: To address sexual and reproductive health (SRH) concerns among people with cystic fibrosis(PwCF), the CF Foundation created the Sexual Health, Reproduction, and Gender Research (SHARING) Working Group. This report summarizes CF community SRH research priorities and workshop discussions/future study planning. Methods: Pre-workshop, we distributed a community prioritization survey on CF SRH research/care. During the workshop, we used results and reviewed existing research to establish research priorities and design studies to address identified knowledge gaps. Results: A total of 303 respondents (85 % PwCF, 15 % caregivers) completed the survey. Highly-rated SRH topics were: 1) effects of CF modulator therapy on sex hormones; 2) effects of sex hormones on CF; 3) fertility; 4) pregnancy; and 5) SRH/mental health. Twenty-four workshop participants established the need for further research on sex hormones and CF, optimizing SRH care provision, and fertility/ART. Conclusion: SRH is an important and emerging area in CF and thoughtful consideration of community perspectives can ensure that future research is relevant and responsive.

11 November 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
TKTraci M. Kazmerski
Traci M. Kazmerski
OSOlivia M. Stransky
Olivia M. Stransky
DLDanielle Rose Lavage
Danielle Rose Lavage
KHKara S. Hughan
Kara S. Hughan
RJRaksha Jain
Raksha Jain
GSGregory S. Sawicki
Gregory S. Sawicki